Somatic Diseases in Autistic Children

Autistic Spectrum Disorder Clinical Trial

— SDA  

Official title:

Medical Monitoring and Somatic Diseases in Children Who Suffer From Autism Spectrum Disorder (ASD)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05077020
• Other study ID #: RECHMPL21_0556
• Status: Completed
• Start date: January 1, 2020
• Est. completion date: October 1, 2021

Study information

• Verified date: October 2021
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

For many reasons, medical monitoring in autistic patients is very difficult. This study is designed to determine the prevalence of comorbid diseases (neurological, cardiac, digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier.

Description:

Mean goal : to determine the prevalence of comorbid diseases (neurological, cardiac, digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier.

Secondary goals :

• to obtain an objective assessment of the "general" monitoring in these patients (vaccinations, growth…)

• to assess their habits (food, sleep, screen exposition)

• to determine, in this monitoring and the habits, vigilance points which will need a specific pediatric consultation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: October 1, 2021
• Est. primary completion date: January 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion criteria:

• consultation after psychiatric evaluation

Exclusion criteria:

• age > 18 years

• Impossibility to obtain the consent of parents / legal representatives.

Related Conditions & MeSH terms

• Autism Spectrum Disorder
• Autistic Disorder
• Autistic Spectrum Disorder
• Disease
• Somatic Disorders

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Determine the prevalence of comorbid diseases	Determine the prevalence of comorbid diseases	1 day